PBM Reforms: House Hearing Suggests Bipartisan Consensus On Legislative Policies Has Limits

There was lots of criticism of pharmacy benefit managers (and a fair amount aimed at pharmaceutical manufacturers) at the oversight hearing. However, Democrats may be more cautious about preserving the benefits PBMs provide versus the downsides in developing reforms.

Bipartisan Consensus
How much can Reps. Jamie Raskin (D-MD), left, and James Comer (R-KY) get done together? • Source: Shutterstock

Pharmacy benefit reform legislation moving in the US Congress has bipartisan support, but it’s not clear whether Democrats and Republicans can agree on what policies to pursue beyond transparency.

House legislation introduced on 8 September combines bipartisan PBM provisions developed by three key committees that focus mainly on detailed...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet